Indegene IPO: Issue subscribed over 69 times on day 3, QIB and retail portion fully booked, check GMP and other details
Indegene IPO day 3: GMP, subscription status, review, other details. Apply or not? The Indigene IPO, totaling ₹1,841.76 crore, comprises a combination of an offer-for-sale (OFS) of 23,932,732 equity shares by the investor selling shareholder, along with a fresh issuance of ₹760 crore. The Indegene IPO received 2,01,81,78,162 share applications on the last day of bidding against offered 2,88,66,677 shares.
The issue was overall subscribed 69.91 times on the third of subscription, as per BSE data. The allocation reserved for Qualified Institutional Buyers (QIBs) saw a subscription rate of 197.55 times, while the portion designated for retail investors garnered a subscription rate of 7.95 times. Additionally, the segment for non-institutional investors recorded an impressive subscription rate of 55.07 times.
The employee reserved portion received 20,24,583 applications, was subscribed 6.48 times. Also read: Indegene IPO sails through smoothly on Day 2; oversubscribed at 7.35x led by NIIs, retail investors. Check GMP The Indegene IPO comprises an offer-for-sale (OFS) of 23,932,732 equity shares by the investor selling shareholder, along with a fresh issue of ₹760 crore.
The company has established a fixed price range of ₹430 to ₹452 per share for the public issue. The business intends to utilize the net proceeds to fulfill the following aims: general corporate requirements, expansion through acquisitions, financing capital expenditure requirements for our company and one of its significant subsidiaries, Indegene, Inc., and settling debts owed by ILSL Holdings, Inc. Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P.
Read more on livemint.com
